CAPTRUST Financial Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,239
| Closed | -$86K | – | 3356 |
|
|
2022
Q2 | $86K | Buy |
1,239
+360
| +41% | +$25K | ﹤0.01% | 2324 |
|
|
2022
Q1 | $73K | Buy |
879
+126
| +17% | +$10.5K | ﹤0.01% | 2506 |
|
|
2021
Q4 | $57K | Sell |
753
-10
| -1% | -$757 | ﹤0.01% | 2570 |
|
|
2021
Q3 | $89K | Sell |
763
-442
| -37% | -$51.6K | ﹤0.01% | 2163 |
|
|
2021
Q2 | $267K | Buy |
1,205
+851
| +240% | +$189K | ﹤0.01% | 1337 |
|
|
2021
Q1 | $47K | Buy |
354
+269
| +316% | +$35.7K | ﹤0.01% | 2463 |
|
|
2020
Q4 | $15K | Hold |
85
| – | – | ﹤0.01% | 2396 |
|
|
2020
Q3 | $10K | Sell |
85
-143
| -63% | -$16.8K | ﹤0.01% | 2281 |
|
|
2020
Q2 | $14K | Buy |
+228
| New | +$14K | ﹤0.01% | 2069 |
|
|
2019
Q4 | – | Sell |
-516
| Closed | -$39K | – | 1523 |
|
|
2019
Q3 | $39K | Buy |
516
+150
| +41% | +$11.3K | ﹤0.01% | 1074 |
|
|
2019
Q2 | $23K | Buy |
+366
| New | +$23K | ﹤0.01% | 1243 |
|